Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Cancer Biology & Medicine
|
September 11, 2018
Extracranial metastasis of anaplastic oligoastrocytoma
Zhuang Kang, Shoubo Yang, Hongmei Zhang, et al.
Clinical Laboratory
|
August 11, 2020
Effect of BRAF/MEK Inhibition on Epithelioid Glioblastoma with BRAFV600E Mutation: a Case Report and Review of the Literature
Yan Li, Shoubo Yang, Chengcheng Hao, et al.
Journal of Inflammation Research
|
August 20, 2024
The Baseline Pan-Immune‑Inflammation Value (PIV) and PILE in Predicting Clinical Outcomes and Therapeutic Response for Primary Central Nervous System Lymphoma
Ling Duan, Wenhui Guo, Shuo Yin, et al.
Journal of Neuro-Oncology
|
April 1, 2024
Machine learning-based pathomics signature of histology slides as a novel prognostic indicator in primary central nervous system lymphoma
Ling Duan, Yongqi He, Wenhui Guo, et al.
Journal of Cancer Research and Therapeutics
|
April 30, 2024
Outcomes, responses, and prognostic analyses of intrathecal combined treatment for leptomeningeal metastasis from lung adenocarcinoma
Sijie Huang, Xun Kang, Ce Wang, et al.
Frontiers in Nutrition
|
March 20, 2023
Association between dietary minerals and glioma: A case-control study based on Chinese population
Weichunbai Zhang, Yongqi He, Xun Kang, et al.
Leukemia & Lymphoma
|
January 17, 2025
Bruton's tyrosine kinase inhibitor zanubrutinib-based regimens in relapsed/refractory primary diffuse large B-cell lymphoma of the central nervous system
Yali Wang, Jiefei Han, Shuo Yin, et al.
CNS Neuroscience & Therapeutics
|
December 8, 2025
Phase 2 Trial of PD-1 Inhibitor Sintilimab in Recurrent/Progressive Meningioma
Yali Wang, Can Wang, Shuo Yin, et al.
Iscience
|
May 10, 2024
Zanubrutinib delays selinexor resistance evolution in biopsy sample-derived primary central nervous system lymphoma models
Xiaohong Zheng, Can Wang, Feng Chen, et al.
Frontiers in Oncology
|
January 30, 2023
Case report: The treatment for olfactory neuroblastoma combined with leptomeningeal carcinomatosis <i>via</i> an ommaya reservoir
Yichen Peng, Xun Kang, Bo Jiang, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Cancer Biology & Medicine
|
September 11, 2018
Extracranial metastasis of anaplastic oligoastrocytoma
Zhuang Kang, Shoubo Yang, Hongmei Zhang, et al.
Clinical Laboratory
|
August 11, 2020
Effect of BRAF/MEK Inhibition on Epithelioid Glioblastoma with BRAFV600E Mutation: a Case Report and Review of the Literature
Yan Li, Shoubo Yang, Chengcheng Hao, et al.
Journal of Inflammation Research
|
August 20, 2024
The Baseline Pan-Immune‑Inflammation Value (PIV) and PILE in Predicting Clinical Outcomes and Therapeutic Response for Primary Central Nervous System Lymphoma
Ling Duan, Wenhui Guo, Shuo Yin, et al.
Journal of Neuro-Oncology
|
April 1, 2024
Machine learning-based pathomics signature of histology slides as a novel prognostic indicator in primary central nervous system lymphoma
Ling Duan, Yongqi He, Wenhui Guo, et al.
Journal of Cancer Research and Therapeutics
|
April 30, 2024
Outcomes, responses, and prognostic analyses of intrathecal combined treatment for leptomeningeal metastasis from lung adenocarcinoma
Sijie Huang, Xun Kang, Ce Wang, et al.
Frontiers in Nutrition
|
March 20, 2023
Association between dietary minerals and glioma: A case-control study based on Chinese population
Weichunbai Zhang, Yongqi He, Xun Kang, et al.
Leukemia & Lymphoma
|
January 17, 2025
Bruton's tyrosine kinase inhibitor zanubrutinib-based regimens in relapsed/refractory primary diffuse large B-cell lymphoma of the central nervous system
Yali Wang, Jiefei Han, Shuo Yin, et al.
CNS Neuroscience & Therapeutics
|
December 8, 2025
Phase 2 Trial of PD-1 Inhibitor Sintilimab in Recurrent/Progressive Meningioma
Yali Wang, Can Wang, Shuo Yin, et al.
Iscience
|
May 10, 2024
Zanubrutinib delays selinexor resistance evolution in biopsy sample-derived primary central nervous system lymphoma models
Xiaohong Zheng, Can Wang, Feng Chen, et al.
Frontiers in Oncology
|
January 30, 2023
Case report: The treatment for olfactory neuroblastoma combined with leptomeningeal carcinomatosis <i>via</i> an ommaya reservoir
Yichen Peng, Xun Kang, Bo Jiang, et al.
Page
of 2